BRIGHT MINDS BIOSCIENCES INC. Payments For Share Issue Costs
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Payments For Share Issue Costs of CAD 0 for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:PaymentsForShareIssueCosts · last filed 2024-12-31
| Period end | Payments For Share Issue Costs 4 month | Payments For Share Issue Costs 12 month |
|---|---|---|
| 2024-09-30 | 0.00 CAD 20-F · filed 2024-12-31 | |
| 2023-09-30 | 26.98K CAD 20-F · filed 2024-12-31 | |
| 2022-09-30 | 260.65K CAD 20-F · filed 2024-12-31 | |
| 2021-09-30 | 290.31K CAD 20-F · filed 2023-12-29 | |
| 2020-09-30 | 0.00 CAD 20-F · filed 2022-12-29 | |
| 2019-09-30 | 0.00 CAD 20-F/A · filed 2022-01-18 |